- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects.
- Zyprexa Diabetes and Weht Gain -
- November 2007 - Zyprexa suicides - Psychology Debunked
- Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa.
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects.
INDIANAPOLIS, Jan 04, 2007 /PRNewswire-First via COEX News Network/ -- Eli Lilly and Company announced today that it has entered into settlement agreements with 14 plaintiffs' firms (or s of plaintiffs' firms) involved in Zyprexa liability litation to resolve the vast majority of remaining product liability claims against Lilly relating to the medication.
Zyprexa Diabetes and Weht Gain -
These settlement agreements follow a master settlement agreement Lilly entered into in June 2005 that covered approximately 8,000 claimants in the United States, as well as additional settlements of approximately 2,500 claims.
November 2007 - Zyprexa suicides - Psychology Debunked
Pharmaceutical company Eli Lilly (makers of Prozac) have agreed to pay upwards of 1.2 billion US dollars to nearly 30,000 patients who claim their bestseller antipsychotic medication, Zyprexa (Olanzapine) has resulted in diabetes, weht gain and other complications and that these risks were downplayed.
Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa.
Of all professions, psychiatrists seem to get into the most trouble. The FDA's request, in a letter to Lilly obtained by Bloomberg, may bolster plaintiffs' suits against the Indianapolis company over side effects tied to Zyprexa, lawyers said.
Zyprexa may 2007:
Rating: 94 / 100
Overall: 90 Rates